Annual D&A
$2.61 M
+$335.00 K+14.71%
December 31, 2022
Summary
- As of February 10, 2025, NLTX annual depreciation & amortization is $2.61 million, with the most recent change of +$335.00 thousand (+14.71%) on December 31, 2022.
- During the last 3 years, NLTX annual D&A has risen by +$2.08 million (+394.70%).
Performance
NLTX Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Related metrics
Quarterly D&A
$381.00 K
+$10.00 K+2.70%
September 30, 2023
Summary
- As of February 10, 2025, NLTX quarterly depreciation & amortization is $381.00 thousand, with the most recent change of +$10.00 thousand (+2.70%) on September 30, 2023.
- Over the past year, NLTX quarterly D&A has dropped by -$209.00 thousand (-35.42%).
Performance
NLTX Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Related metrics
TTM D&A
$2.01 M
-$209.00 K-9.42%
September 30, 2023
Summary
- As of February 10, 2025, NLTX TTM depreciation & amortization is $2.01 million, with the most recent change of -$209.00 thousand (-9.42%) on September 30, 2023.
- Over the past year, NLTX TTM D&A has dropped by -$590.00 thousand (-22.69%).
Performance
NLTX TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Related metrics
NLTX Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +14.7% | -35.4% | -22.7% |
| 3 y3 years | +394.7% | -13.6% | +23.0% |
| 5 y5 years | +625.6% | - | +280.7% |
NLTX Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | -12.8% | -46.9% | -2.6% | -23.0% | at low |
| 5 y | 5-year | at high | -79.8% | -46.9% | -41.7% | -23.0% | -73.7% |
| alltime | all time | at high | -95.0% | -46.9% | -111.9% | -23.0% | -100.0% |
Neoleukin Therapeutics Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2023 | - | $381.00 K(+2.7%) | $2.01 M(-9.4%) |
| Jun 2023 | - | $371.00 K(-39.7%) | $2.22 M(-13.5%) |
| Mar 2023 | - | $615.00 K(-4.4%) | $2.57 M(-1.8%) |
| Dec 2022 | $2.61 M(+14.7%) | $643.00 K(+9.0%) | $2.61 M(+0.5%) |
| Sep 2022 | - | $590.00 K(-17.8%) | $2.60 M(-0.1%) |
| Jun 2022 | - | $718.00 K(+8.6%) | $2.60 M(+7.3%) |
| Mar 2022 | - | $661.00 K(+4.8%) | $2.43 M(+6.5%) |
| Dec 2021 | $2.28 M(+25.0%) | $631.00 K(+6.6%) | $2.28 M(+8.2%) |
| Sep 2021 | - | $592.00 K(+9.2%) | $2.10 M(+7.7%) |
| Jun 2021 | - | $542.00 K(+5.9%) | $1.95 M(+19.6%) |
| Mar 2021 | - | $512.00 K(+11.5%) | $1.63 M(-10.3%) |
| Dec 2020 | $1.82 M | $459.00 K(+4.1%) | $1.82 M(+11.4%) |
| Sep 2020 | - | $441.00 K(+98.6%) | $1.63 M(+24.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2020 | - | $222.00 K(-68.2%) | $1.31 M(+12.9%) |
| Mar 2020 | - | $699.00 K(+157.0%) | $1.17 M(+120.6%) |
| Dec 2019 | $528.00 K(+82.7%) | $272.00 K(+123.0%) | $528.00 K(+106.3%) |
| Sep 2019 | - | $122.00 K(+69.4%) | $256.00 K(+91.0%) |
| Jun 2019 | - | $72.00 K(+16.1%) | $134.00 K(+116.1%) |
| Mar 2019 | - | $62.00 K(-237.2%) | $62.00 K(>+9900.0%) |
| Dec 2018 | $289.00 K(-19.7%) | - | - |
| Dec 2017 | $360.00 K(+175.2%) | - | - |
| Dec 2013 | - | -$45.20 K(-405.4%) | $0.00(-100.0%) |
| Sep 2013 | - | $14.80 K(-5.1%) | $45.20 K(+48.7%) |
| Jun 2013 | - | $15.60 K(+5.4%) | $30.40 K(+105.4%) |
| Mar 2013 | - | $14.80 K | $14.80 K |
| Dec 2012 | $130.80 K | - | - |
FAQ
- What is Neoleukin Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for Neoleukin Therapeutics?
- What is Neoleukin Therapeutics annual D&A year-on-year change?
- What is Neoleukin Therapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Neoleukin Therapeutics?
- What is Neoleukin Therapeutics quarterly D&A year-on-year change?
- What is Neoleukin Therapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for Neoleukin Therapeutics?
- What is Neoleukin Therapeutics TTM D&A year-on-year change?
What is Neoleukin Therapeutics annual depreciation & amortization?
The current annual D&A of NLTX is $2.61 M
What is the all time high annual D&A for Neoleukin Therapeutics?
Neoleukin Therapeutics all-time high annual depreciation & amortization is $2.61 M
What is Neoleukin Therapeutics annual D&A year-on-year change?
Over the past year, NLTX annual depreciation & amortization has changed by +$335.00 K (+14.71%)
What is Neoleukin Therapeutics quarterly depreciation & amortization?
The current quarterly D&A of NLTX is $381.00 K
What is the all time high quarterly D&A for Neoleukin Therapeutics?
Neoleukin Therapeutics all-time high quarterly depreciation & amortization is $718.00 K
What is Neoleukin Therapeutics quarterly D&A year-on-year change?
Over the past year, NLTX quarterly depreciation & amortization has changed by -$209.00 K (-35.42%)
What is Neoleukin Therapeutics TTM depreciation & amortization?
The current TTM D&A of NLTX is $2.01 M
What is the all time high TTM D&A for Neoleukin Therapeutics?
Neoleukin Therapeutics all-time high TTM depreciation & amortization is $2.61 M
What is Neoleukin Therapeutics TTM D&A year-on-year change?
Over the past year, NLTX TTM depreciation & amortization has changed by -$590.00 K (-22.69%)